visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Amicus Therapeutics

    Get Full Access

    Description

    • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data; gene therapies for Fabry and Pompe diseases, as well as for various types of Batten diseases; enzyme replacement therapies for Pompe diseases; and CDKL5 deficiency disorder product candidates. The company also has additional gene therapies in active preclinical development, including gene therapies for mucopolysaccharidosis type IIIB, as well as a next generation program in mucopolysaccharidosis type IIIA. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
    • location

      Headquarters:1 Cedar Brook Drive , Cranbury, New Jersey, United States

      More
    • Amicus Therapeutics phone

      Phone Number: +1 609-662-2000

    • Amicus Therapeutics website

      Website: https://www.amicusrx.com

    • Amicus Therapeutics employees

      Employees:531

    • Amicus Therapeutics revenue

      Revenue:$250 - 500M

    • Amicus Therapeutics legal name

      Legal Name:Amicus Therapeutics

    • Amicus Therapeutics's Social Media

      Amicus Therapeutics linkedin Amicus Therapeutics twitter
    • done Is this data correct?

    • |  NAICS Code: 541714  |

        NYSE: FOLD

      Show More
    Person level website identification

    CEO for Amicus Therapeutics

    Paulette Caswell

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    David Clark

    Chief People Officer

    Daphne Quimi

    Chief Financial Officer

    Jill Weimer

    Chief Science Officer

    Jim Galea

    President

    Sebastien Martel

    Chief Business Officer

    Frequently Asked Questions regarding Amicus Therapeutics

    • Where are Amicus Therapeutics's Headquarters?

      Amicus Therapeutics's Headquarters are in 1 Cedar Brook Drive ,Cranbury,New Jersey,United States

    • What is Amicus Therapeutics's phone number?

      Amicus Therapeutics's phone number is +1 609-662-2000

    • What is Amicus Therapeutics's stock symbol?

      Amicus Therapeutics's stock symbol is FOLD

    • What is Amicus Therapeutics's official website?

      Amicus Therapeutics's official website is https://www.amicusrx.com

    • What is Amicus Therapeutics's Revenue?

      Amicus Therapeutics's revenue is $250 - 500M

    • What is Amicus Therapeutics's NAICS code?

      Amicus Therapeutics's NAICS code is 541714

    • How many employees are working in Amicus Therapeutics

      Amicus Therapeutics has 531 employees

    • What is Amicus Therapeutics's Industry?

      Amicus Therapeutics is in the industry of Biotechnology

    Company Directory